News Related to Respiratory Infections

Related coverage linked through entity extraction aliases.

Altesa Raises $75M Series B to Advance Rhinovirus Treatment for COPD Patients

Mar 19, 2026

Altesa BioSciences closed an oversubscribed $75 million Series B financing led by Forbion with participation from Sanofi to advance vapendavir, a first-in-class oral antiviral targeting rhinovirus infections in COPD patients.

CAR-T Therapy Preserves Fertility in Lupus; Bispecific Antibodies Show Promise in Autoimmune Diseases

Feb 24, 2026

A 24-year-old woman with refractory lupus achieved two successful pregnancies following dual-target CAR-T cell therapy, while bispecific T cell engagers showed efficacy in treatment-refractory antisynthetase syndrome and systemic sclerosis patients.